As of 2026-06-14, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -10.60 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.87 USD, the upside of Olema Pharmaceuticals Inc is -207.38%.
Based on its market price of 9.87 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 207.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.60 - -10.60 | -10.60 | -207.38% |
| P/E | (39.85) - (47.48) | (43.82) | -544.0% |
| DDM - Stable | (20.17) - (86.83) | (53.50) | -642.0% |
| DDM - Multi | (16.03) - (55.18) | (25.03) | -353.6% |
| Market Cap (mil) | 862.14 |
| Beta | -0.61 |
| Outstanding shares (mil) | 87.35 |
| Enterprise Value (mil) | 812.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.78% |
| Cost of Debt | 5.00% |
| WACC | 8.76% |